BMJ editor asks chief medical officer to set up inquiry into statin risks and benefits.
作者信息
Hawkes Nigel
机构信息
London.
出版信息
BMJ. 2016 Sep 16;354:i5046. doi: 10.1136/bmj.i5046.
PMID:27638005
Abstract
摘要
相似文献
1
BMJ editor asks chief medical officer to set up inquiry into statin risks and benefits.
BMJ. 2016 Sep 16;354:i5046. doi: 10.1136/bmj.i5046.
2
England's chief medical officer asks for review of drug evaluation in wake of statins controversy.在他汀类药物引发争议后，英国首席医疗官要求对药物评估进行审查。
BMJ. 2015 Jun 16;350:h3300. doi: 10.1136/bmj.h3300.
3
Quality and compliance: the dual responsibilities of the chief medical officer.质量与合规：首席医疗官的双重职责
Physician Exec. 2009 May-Jun;35(3):22-5.
4
Statin-use debate creates furor at The BMJ.他汀类药物使用的争论在《英国医学杂志》上引发轩然大波。
CMAJ. 2014 Aug 5;186(11):E405-6. doi: 10.1503/cmaj.109-4825. Epub 2014 Jun 16.
5
Lessons Learned on a Journey from Surgeon to Chief Quality Officer.从外科医生到质量总监之旅的经验教训
Jt Comm J Qual Patient Saf. 2016 Feb;42(2):92-5. doi: 10.1016/s1553-7250(16)42011-8.
6
The 50 most powerful physician executives in healthcare, 2007.
Mod Healthc. 2007 May 7;37(19):24, 26, 28 passim.
7
Two papers in The BMJ with statin side effect errors shouldn't be retracted, independent panel concludes.独立小组得出结论，《英国医学杂志》上两篇存在他汀类药物副作用错误的论文不应被撤回。
BMJ. 2014 Aug 4;349:g4993. doi: 10.1136/bmj.g4993.
8
Physician executives explore "new science" frontier. Bridging the communications gap between medical staff and administration.医师管理人员探索“新科学”前沿。弥合医务人员与管理层之间的沟通差距。
Physician Exec. 2002 Jan-Feb;28(1):81-3.
9
Letter From the Editor: The end.来自编辑的信：结束。
Clin Adv Hematol Oncol. 2016 Dec;14(12):942.
10
The chief medical officer: a critical success factor.首席医疗官：一个关键的成功因素。
Physician Exec. 2009 Sep-Oct;35(5):60-2.
引用本文的文献
1
Prescribing statins in general practice: who decides?在全科医疗中开具他汀类药物：由谁来决定？
Br J Gen Pract. 2017 Jun;67(659):246-247. doi: 10.3399/bjgp17X690953.
Zotero 插件